Cardiac Arrhythmias at Extreme Altitude

NCT05676398 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2023-01-18

No results posted yet for this study

Summary

Background: Exposure to high altitudes has been associated with an increased risk of cardiac arrhythmias in healthy subjects and an increased risk of sudden cardiac death.

Aim: The aim of the present study is to evaluate the risk and the incidence of cardiac arrhythmias at extreme altitude.

Methods: This is a prospective cohort study of healthy volunteers determined to climb Mount Everest. Subjects will be evaluated for eligibility by electrocardiography and echocardiography. All study participants will undergo ambulatory rhythm monitoring in their home environment within 12 weeks of the climb. Subsequently, ambulatory rhythm monitoring will be repeated during the ascent from basecamp to the summit of Mount Everest. The primary endpoint will be the composite of supraventricular and ventricular tachyarrhythmias, and bradyarrhythmias.

Conditions

  • Arrhythmias, Cardiac
  • Tachycardia, Ventricular
  • Tachycardia, Supraventricular
  • Bradycardia

Interventions

DIAGNOSTIC_TEST

Ambulatory rhythm recording

Ambulatory rhythm recording by use of a wearable patch-type device.

Sponsors & Collaborators

  • National Academy of Medical Sciences, Nepal

    collaborator OTHER_GOV
  • Insel Gruppe AG, University Hospital Bern

    lead OTHER

Principal Investigators

  • Thomas Pilgrim, MD · Bern University Hospital, University of Bern, Switzerland

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-01-01
Primary Completion
2023-06-01
Completion
2023-09-30

Countries

  • Nepal

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05676398 on ClinicalTrials.gov